Home
Journals
Focus
Videos
Language
English
中文简体
Sign in
All
Title
Author
Year
Keyword
Text
Search
Journals
Engineering
4
Strategic Study of CAE
1
Frontiers of Chemical Science and Engineering
2
Frontiers of Medicine
29
Selected
Sort by
select
Time desc
Time asc
Export
EndNote
RefWorks
NoteExpress
BibTe
Ref Manager
ProCite
Immunometabolism: a new dimension in immunotherapy resistance
immune cell, immunometabolism, metabolic reprogramming, immunotherapy, resistance, tumor microenvironment, immune checkpoint inhibitor
Frontiers of Medicine
2023.17(4) 585-616
Therapeutic Characterization of
131
I-Labeled Humanized Anti-B7-H3 Antibodies for Radioimmunotherapy for Glioblastoma
Article
Fengqing Fu Meng Zheng Shandong Zhao Yan Wang Minzhou Huang Hanqing Chen Ziyi Huang Kaijie Zhang Liyan Miao Xueguang Zhang
B7-H3, Radioimmunotherapy, Glioblastoma, Pharmacokinetics, Pharmacodynamics
Engineering
2023.30(11) 190-202
Dihydroartemisinin increased the abundance of by YAP1 depression that sensitizes hepatocellular carcinoma to anti-PD-1 immunotherapy
hepatocellular carcinoma, YAP1,
Akkermansia muciniphila
, anti-PD-1, dihydroartemisinin, bile acid
Frontiers of Medicine
2023.17(4) 729-746
Immunosuppressive tumor microenvironment contributes to tumor progression in diffuse large B-cell lymphoma upon anti-CD19 chimeric antigen receptor T therapy
anti-CD19 chimeric antigen receptor T, immunotherapy, diffuse large B cell lymphoma, tumor microenvironment, tumor-associated macrophage, metabolism
Frontiers of Medicine
2023.17(4) 699-713
Chinese expert consensus on oral drugs for the treatment of mature B-cell lymphomas (2020 edition)
B-cell lymphoma, oral drug, targeted therapy, immunotherapy, COVID-19 pandemic
Frontiers of Medicine
2022.16(5) 815-826
CAR T cells redirected against tumor-specific antigen glycoforms: can low-sugar antigens guarantee a sweet success?
cancer immunotherapy, chimeric antigen receptor, solid tumors, tumor-associated antigen, glycosylation, O-glycans, adoptive cell therapy
Frontiers of Medicine
2022.16(3) 322-338
Analysis of interactions of immune checkpoint inhibitors with antibiotics in cancer therapy
tumor immunotherapy, immune checkpoint inhibitor, antibiotics, gut microbiota, drug–drug interaction
Frontiers of Medicine
2022.16(3) 307-321
Preclinical characterization and comparison between CD3/CD19 bispecific and novel CD3/CD19/CD20 trispecific antibodies against B-cell acute lymphoblastic leukemia: targeted immunotherapy for acute lymphoblastic leukemia
B-cell acute lymphoblastic leukemia, bispecific antibody, trispecific antibody, CD19, CD20
Frontiers of Medicine
2022.16(1) 139-149
Emerging immunological strategies: recent advances and future directions
cancer immunotherapy, bispecific antibodies, small molecules, chimeric antigen receptor T therapy, cancer vaccines
Frontiers of Medicine
2021.15(6) 805-828
CAR T-cell immunotherapy: a powerful weapon for fighting hematological B-cell malignancies
CAR T cells, hematological malignancies, review
Frontiers of Medicine
2021.15(6) 783-804
Prev
Next
Related search
Relevant information